Translational Immunology Training Program
转化免疫学培训计划
基本信息
- 批准号:10186683
- 负责人:
- 金额:$ 37.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
This is a revised, competitive renewal, T32 application in which we have coalesced and reconfigured two
previously distinct and successful T32 programs at the Icahn School of Medicine at Mount Sinai (ISMMS), a
post-doc program in Transplant Immunology [(P Heeger, former program director (PD)] and a pre-/post-doc
program in Immunology (S Lira, former PD), into an expanded pre- and post-doctoral training program in
Translational Immunology (P Heeger and S Lira Co-PDs). Combining the programs will a) enhance
translational immunology training (including training in transplantation) through cross fertilization (e.g. exposing
trainees in cancer immunology to transplant immunology, immunodeficiency and autoimmunity through a joint
training venue) b) leverage common training faculty and institutional resources, as well as a revised
immunology-focused, administrative infrastructure (including education, career development and evaluation
processes) to enhance function and efficiency of the training experience, and c) limit overlap among training
faculty. Additional rationale include 1) our success over the past 16 years in attracting and training pre- and
post-doctoral MD, PhD and MD/PhD trainees into immunology research careers, 2) the continued need for
improving outcomes of immune-mediated diseases 3) our desire to positively impact the education of future
basic and translational investigators in immunology, and 4) the fact that our training environment and research
foci are well-suited to offer diverse basic and translational immunology research opportunities for trainees. The
exceptional ability of Mount Sinai's immunology community to make fundamental discoveries, to translate the
results into novel and effective diagnostic and therapeutic strategies, and to incorporate pre- and post-doc
training into its research mission underscores the significance of this revised training program. The overall
objective of this program is to attract and train talented MD/PhD and PhD students and post-docs over 2 year
periods, for successful, independent careers in immunology relevant to human disease. We have a diverse,
well-funded faculty with broad interest in immunology and a strong pool of pre- and post-doc trainees that
includes significant numbers of underrepresented minorities. The program is designed to provide training by
individual mentors performing research in all aspects of Immunology relevant to human disease. The program
is supported with strong oversight and administrative structure, significant didactic training in Immunology,
scientific writing and career development, and contains newly added state of the art evaluation approaches
with defined goals and benchmarks for success so as to optimize the development of independent academic
researchers in the field.
项目概要/摘要
这是一个经过修订的、竞争性更新的 T32 应用程序,我们在其中合并并重新配置了两个
西奈山伊坎医学院 (ISMMS) 先前独特且成功的 T32 项目
移植免疫学博士后项目 [(P Heeger,前项目主任 (PD)] 和博士前/博士后
免疫学项目(S Lira,前PD),扩展为博士前和博士后培训项目
转化免疫学(P Heeger 和 S Lira Co-PD)。结合这些程序将 a) 增强
通过交叉受精(例如暴露
癌症免疫学学员通过联合移植免疫学、免疫缺陷和自身免疫
培训地点)b)利用共同的培训师资和机构资源,以及修订后的培训资源
以免疫学为重点的行政基础设施(包括教育、职业发展和评估
流程)以增强培训体验的功能和效率,以及 c)限制培训之间的重叠
学院。其他理由包括 1) 我们在过去 16 年中在吸引和培训学前和学前教育方面取得了成功
博士后医学博士、博士和医学博士/博士生进入免疫学研究职业,2) 持续需要
改善免疫介导疾病的结果 3) 我们希望对未来的教育产生积极影响
免疫学的基础和转化研究人员,以及 4) 我们的培训环境和研究
foci 非常适合为学员提供多样化的基础和转化免疫学研究机会。这
西奈山免疫学界做出基本发现、转化
结果转化为新颖有效的诊断和治疗策略,并将博士前和博士后纳入
研究任务培训强调了这一修订后的培训计划的重要性。整体
该计划的目标是吸引和培训有才华的医学博士/博士生和博士后,为期两年
时期,在与人类疾病相关的免疫学领域取得成功、独立的职业生涯。我们拥有多元化、
资金雄厚、对免疫学有广泛兴趣的教师队伍以及大量博士前和博士后实习生
包括大量代表性不足的少数族裔。该计划旨在提供培训
个人导师在与人类疾病相关的免疫学的各个方面进行研究。该计划
得到强有力的监督和管理结构、重要的免疫学教学培训的支持,
科学写作和职业发展,并包含新添加的最先进的评估方法
具有明确的目标和成功基准,以优化独立学术的发展
该领域的研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Scott Heeger其他文献
Peter Scott Heeger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Scott Heeger', 18)}}的其他基金
Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation
肾移植中生物标志物引导的 CNI 替代评估
- 批准号:
10654057 - 财政年份:2022
- 资助金额:
$ 37.94万 - 项目类别:
Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation
肾移植中生物标志物引导的 CNI 替代评估
- 批准号:
10488428 - 财政年份:2022
- 资助金额:
$ 37.94万 - 项目类别:
Biomarker Guided CNI Substitution in Kidney Transplantation
生物标志物引导肾移植中的 CNI 替代
- 批准号:
9926399 - 财政年份:2020
- 资助金额:
$ 37.94万 - 项目类别:
Multiparametric mapping of Covid-19 immune responses in Kidney transplant recipients
肾移植受者 Covid-19 免疫反应的多参数绘图
- 批准号:
10241179 - 财政年份:2020
- 资助金额:
$ 37.94万 - 项目类别:
Cell Death Pathways and Heart Transplant Rejection
细胞死亡途径和心脏移植排斥
- 批准号:
10162490 - 财政年份:2017
- 资助金额:
$ 37.94万 - 项目类别:
Targeting factor B to prevent transplant rejection
靶向因子 B 预防移植排斥
- 批准号:
8873752 - 财政年份:2015
- 资助金额:
$ 37.94万 - 项目类别:
Targeting factor B to prevent transplant rejection
靶向因子 B 预防移植排斥
- 批准号:
9000104 - 财政年份:2015
- 资助金额:
$ 37.94万 - 项目类别:
Individualizing Therapy for Kidney and Heart Transplant Recipients
肾脏和心脏移植受者的个体化治疗
- 批准号:
8100584 - 财政年份:2010
- 资助金额:
$ 37.94万 - 项目类别:
Noninvasive Markers and Transplant Outcome in Humans
人类非侵入性标志物和移植结果
- 批准号:
7919132 - 财政年份:2009
- 资助金额:
$ 37.94万 - 项目类别:
Cross-disciplinary Postdoctoral Training Program in Transplant Research
移植研究跨学科博士后培养项目
- 批准号:
7849905 - 财政年份:2008
- 资助金额:
$ 37.94万 - 项目类别:
相似国自然基金
天元数学东北地区青年教师培训项目
- 批准号:11826007
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:数学天元基金项目
天元数学东北地区青年教师培训项目
- 批准号:11726007
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:数学天元基金项目
相似海外基金
Mrgprb2 mediated neuroinflammation after cerebral ischemia
Mrgprb2介导脑缺血后的神经炎症
- 批准号:
10644182 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Investigating the interplay between senescence and T cell immunity
研究衰老与 T 细胞免疫之间的相互作用
- 批准号:
10643160 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
A multi-omic and integrative longitudinal evaluation of the role of lipid, antioxidant, and osmoprotectant metabolites in the genitourinary syndrome of menopause by race and ethnicity.
按种族和民族对脂质、抗氧化剂和渗透保护代谢物在更年期泌尿生殖综合征中的作用进行多组学和综合纵向评估。
- 批准号:
10643444 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Pathogenic T cells in discoid lupus erythematosus
盘状红斑狼疮中的致病性 T 细胞
- 批准号:
10664134 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别: